Skip to main content
. 2022 Nov 25;9:1052055. doi: 10.3389/fmed.2022.1052055

TABLE 2.

Diseases and patients’ presentation scenarios for which VC was valued.

Digital user (n = 77)
Digital non-user (n = 128)
First
presentation % (n)
Follow-up
presentation % (n)
First
presentation % (n)
Follow-up presentation % (n)
Osteoarthritis 9.1 (7) 48.1 (37) 4.7 (6) 17.2 (22)
Axial spondyloarthritis 7.8 (6) 57.1 (44) 1.6 (2) 22.7 (29)
Fibromyalgia 9.1 (7) 44.2 (34) 7.0 (9) 18.8 (24)
Juvenile idiopathic arthritis 3.9 (3) 44.2 (34) 1.6 (2) 16.4 (21)
Connective tissue diseases 3.9 (3) 42.9 (33) 0.8 (1) 16.4 (21)
Crystal arthropathies 5.2 (4) 46.7 (36) 1.6 (2) 18.8 (24)
Osteoporosis 10.4 (8) 40.3 (31) 4.7 (6) 19.5 (25)
Psoriatic arthritis 5.2 (4) 57.1 (44) 1.6 (2) 21.9 (28)
Rheumatoid arthritis 6.5 (5) 59.7 (46) 2.3 (3) 21.9 (28)
Vasculitides 3.9 (3) 32.5 (25) 1.6 (2) 16.4 (21)